Triple Assay of Rectal Mucus in the Diagnosis of Colorectal Cancer

Recruiting Observational Study
Colorectal Cancer Adenoma Colon Polyp
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 99
Sex
Any
Study type
Observational
Participants needed
6,600 (estimated)
Sponsor
Origin Sciences · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Development of a multiomics assay for use on OriColTM sampled rectal mucus for detection of cancer and significant polyps in symptomatic patients on the Colorectal Urgent Suspected Cancer pathway.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Patients 18 years and over 2. Patients referred from primary care to the 'urgent suspected cancer' CRC pathway during the study period. 3. Patients who provide voluntary written informed consent to participate in the study. Exclusion Criteria: 1. Patients who are unable to …
Contacts

Jon Lacy-Colson, FRCS

+44(0)1743261000

jon.lacy-colson@sath.nhs.uk

CONTACT

Ian Daniels, FRCS

+44(0)1256 750490

ian.daniels@originsciences.com

CONTACT